首页|基于高通量测序研究清润方改善2型糖尿病大鼠肝脏胰岛素抵抗的作用机制

基于高通量测序研究清润方改善2型糖尿病大鼠肝脏胰岛素抵抗的作用机制

扫码查看
目的:基于高通量转录组测序(RNA-seq)研究清润方改善2型糖尿病(T2DM)大鼠肝脏胰岛素抵抗的作用机制.方法:采用高脂饲料喂养联合链脲佐菌素腹腔注射构建T2DM大鼠模型,将成模大鼠采用随机数字表随机分为模型组,二甲双胍组(150 mg/kg),清润方大(11.2 g/kg)、中(5.6 g/kg)、小(2.8 g/kg)剂量组,另设正常组,灌胃干预8周.观察空腹血糖(FBG)、胰岛素抵抗指数(IRI)、胰岛素敏感指数(ISI)变化,利用RNA-seq结合生物信息学分析筛选差异表达的长链非编码RNA(lncRNA)、微RNA(miRNA)、信使RNA(mRNA),对差异基因进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析及qPCR验证,构建竞争性内源性RNA(ceRNA)调控网络.结果:与模型组比较,干预第6、8周清润方大剂量组FBG明显降低(P<0.05);第8周清润方各剂量组IRI降低(P<0.01),清润方大、小剂量组ISI升高(P<0.01,P<0.05).通过差异表达筛选得到85个关键mRNA、12个miRNA、37个lncRNA,通过蛋白质-蛋白质相互作用(PPI)网络得到12个核心基因,并构建lncRNA-miRNA-mRNA网络.KEGG富集分析显示,差异基因主要涉及Janus激酶/信号转导及转录活化因子(JAK-STAT)、过氧化物酶体增殖物激活受体(PPAR)、氨基酸代谢、脂质代谢等通路.结论:清润方可能通过lncRNA-miRNA-mRNA网络调控CYP2、Acer2等基因,并影响Lpin1、Insig1等基因和PPAR、JAK-STAT、氨基酸代谢、脂质代谢等信号通路,改善2型糖尿病大鼠肝脏胰岛素抵抗.
Mechanism of Qingrun Formula in Improving Hepatic Insulin Resistance of Rats with Type 2 Diabetes Mellitus Based on High-throughput Sequencing
Objective:To explore the mechanism of Qingrun Formula in improving hepatic insulin resistance in rats with type 2 di-abetes mellitus(T2DM)through high-throughput RNA sequencing(RNA-seq).Methods:A T2DM model of rats was established by feeding rats a high-fat diet combined with intraperitoneal injection of streptozotocin(STZ).The successfully modeled rats were ran-domly divided into the model group,metformin group(150 mg/kg),and high-dose(11.2 g/kg),medium-dose(5.6 g/kg),and low-dose(2.8 g/kg)groups of Qingrun Formula,and a normal control group was set up.The rats were given intragastric intervention for eight weeks.Changes in fasting blood glucose(FBG),insulin resistance index(IRI),and insulin sensitivity index(ISI)were ob-served among the groups.RNA-seq technology combined with bioinformatics analysis was used to screen differentially expressed long-chain non-coding RNA(lncRNA),micro RNA(miRNA),and messenger RNA(mRNA).Gene ontology(GO)and Kyoto ency-clopedia of genes and genomes(KEGG)enrichment analyses and qPCR verification of differentially expressed genes were per-formed,and regulatory networks of competitive endogenous RNA(ceRNA)were constructed.Results:Compared with that in the model group,the FBG in the high-dose group of Qingrun Formula decreased significantly in the 6th and 8th week of intervention(P<0.05).In the 8 th week of intervention,the IRI in all groups of Qingrun Formula decreased significantly(P<0.01),while that in the high-dose and low-dose groups of Qingrun Formula increased significantly(P<0.01,P<0.05).85 key mRNA,12 miRNA,and 37 lncRNA were obtained through differential expression screening.12 core genes were obtained by protein-protein interaction(PPI)network,and the network of lncRNA-miRNA-mRNA was constructed.KEGG enrichment analysis revealed that differentially expressed genes were mainly involved in pathways such as JAK-STAT,PPAR,amino acid metabolism,and lipid metabolism.Con-clusion:Qingrun Formula may improve hepatic insulin resistance of rats with T2DM by regulating CYP2 and Acer2 genes through the lncRNA-miRNA-mRNA network and affecting Lpin1 and Insig1 genes,as well as PPAR,JAK-STAT,amino acid metabolism,lipid metabolism,and other signaling pathways.

Qingrun FormulaType 2 diabetes mellitusInsulin resistanceTranscriptome sequencingNetworks of competitive endogenous RNADifferential geneSignaling pathwayMechanism

卜祥伟、郝晓晖、张美珍、王泽、王皓朔、史佩玉、张润云、倪青、林兰

展开 >

中国中医科学院广安门医院内分泌科,北京,100053

天津中医药大学第一附属医院内分泌科,天津,300381

清润方 2型糖尿病 胰岛素抵抗 转录组测序 竞争性内源性RNA网络 差异基因 信号通路 作用机制

国家自然科学基金面上项目

81973685

2024

世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
年,卷(期):2024.19(11)
  • 11